DNAlytics
Chemin Du Cyclotron 6
1348 Ottignies-Louvain-La-Neuve
BE
DNAlytics
Foundation date
03/04/2012
Sector
#Biotechnology / R&D ServicesSubsector
- #R&D Services - Bioinformatics
- #R&D Services - CRO (Contract Research Organization)
- #R&D Services - Diagnostic services
- #R&D Services - Genomics
- #R&D Services - Proteomics
DNAlytics bases its activity on a Data Mining platform that it applies to develop personalized medicine solutions, from R&D to market access: diagnostic, prognostic and treatment response prediction, coupled with biomarker identification. DNAlytics has two main offers based on this technology platform: an expert consulting activity for pharmaceutical, biotech or IVD companies, and a product pipeline development. Its 1st product is RheumaKit, an early diagnostic solution for undifferentiated arthritis.
Upcoming events
All events-
2809 '22
NLSDays 2022
Event by: SwedenBIO -
2809 '22
Neurotechnologies
Event by: VIB -
0712 '22
Emerging Applications of Microbes (2nd edition)
Event by: VIB
Latest news
More news-
Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®
6 hours ago
Read more
-
S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities
Tuesday August 2nd 2022
Read more
-
Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial
Monday August 1st 2022
Read more